He reveals to the reader how the fraud was executed. Carreyrou tears apart the legendary company that built on lies. He drew upon the comprehensive background detail they provided to uncover the truth. In his research for the book, Carreyrou interviewed over 150 people, including sixty former employees.
“Bad Blood” was named one of the best books of 2018 by NPR, New York Times Book Review, Time, Wall Street Journal, Washington Post, and was the recipient of Financial Times and McKinsey Business Book of the Year Award.More Content On Bookey Best Book Summary App ().įor nearly a ten billion dollar fraud, what meticulous planning is required? How did a school dropout with no medical background deceive the medical technology establishment and even political giants? In “Bad Blood”, the author, John Carreyrou, uses a calm and objective style of writing to reveal the shocking fraudulent activity at the heart of Theranos, Elizabeth Holmes’ company. “Bad Blood” is the riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.įor his extensive coverage of Theranos, Carreyrou was awarded the George Polk Award for Financial Reporting, the Gerald Loeb Award for Distinguished Business and Financial Journalism for beat reporting, and the Barlett & Steele Silver Award for Investigative Business Journalism. There was just one problem: the technology didn’t work. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares that valued the company at more than $9 billion, putting Holmes’ worth at an estimated $4.7 billion. In 2014, Theranos founder and CEO Elizabeth Holmes was widely viewed as the female Steve Jobs: a brilliant Stanford dropout whose startup promised to revolutionize the medical industry by making it easier and faster to test blood for diseases.
0 kommentar(er)
